Skip to content

Clinical trials

Lung Diseases trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Country / region: Mexico Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20111
20121
20131
20141
20161
20181
20193
20201
20221
20232
20243
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting9
Active, not recruiting2
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca7
Bayer2
Eli Lilly and Company2
Pfizer2
United Therapeutics2
GlaxoSmithKline1
Hoffmann-La Roche1
Instituto Nacional de Cancerologia de Mexico1
Novartis Pharmaceuticals1
Nuvalent Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases22
Pulmonary Disease, Chronic Obstructive7
Respiratory Tract Diseases7
Carcinoma, Non-Small-Cell Lung5
Asthma3
Bronchial Diseases3
Bronchitis, Chronic3
COVID-193
Cardiovascular Diseases3
Connective Tissue Diseases3

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.